adrenal diseases: clinical overview and management · adrenal androgens • play a significant...
TRANSCRIPT
AdrenalDiseases:ClinicalOverviewandManagement
DeepikaReddy,March7,201210:30AM
DepartmentofEndocrinology
ObjecFves
• Understandbasicadrenalphysiology(steroidogenesis)
• UnderstandthefuncFonofvariousadrenalhormones
• Reviewcommonformsofcongenitaladrenalhyperplasia
• Reviewhormonaldeficiencyandhormonalexcessstates.
HistologyoftheAdrenalGland
TheAdrenalGland
OuterZoneofCortex:Glomerulosa Siteofaldosterone(mineralocorFcoid)producFon
MiddleZoneofCortex:Fasciculata
SiteofcorFsol(glucocorFcoid)producFon InnerZoneofCortex:ReFcularis
SiteofandrogenproducFon AdrenalMedulla
siteofcatecholamineproducFon
FuncFonofAdrenalHormones
• Aldosterone– EffectisonrenalcollecFngtubuleandpartofthedistalconvolutedtubule.Itservestoincreasesodium,waterreabsorpFonandpotassiumexcreFon.
– Aldosteroneisthereforeinvolvedinmaintenanceofextracellularfluidvolume,NaandKconcentraFon
– AcFvatedbytherenin‐angiotensinsystem
GlucocorFcoidFuncFonFigfrom‘Endocrinologyanintegratedapproach’:S.S.NusseyandS.A.Whitehead
GlucocorFcoidFuncFon
Liver:Raisebloodglucose:ByincreasinghepaFcglucoseproducFonandreduced
peripheraluFlizaFon Muscle:Aminoacidreleasefrommuscleforgluconeogenesis,chronicusecauses
musclewasFng AdiposeTissue:Lipolysis,o`encounteredbythelipogenesisinducedbyinsulin Bone:DecreasedosteoblastaciFvity,increasedosteoclastacFvity,decreased
calciumabsorpFonfromgutanddecreasedresponsivenesstovitaminD ImmuneSystem:AnF‐inflammatoryproperFes/ImmunesuppressionbymulFple
mechanisms Skin:affectsfibroblastfuncFon Cardiovascular:potenFatestheaffectofcatecholaminesandAngiotensinIIonthe
vasculature. CNS:maybeassociatedwithdepression,psychosis Kidney:IncreasesrenalbloodflowandincreasesGFR.(InhighconcentraFons,canhavemineralocorFcoideffect)
AdrenalAndrogens
• Playasignificantroleingonadaldevelopmentinuteroandyoungchildren.
• Inadultmales,adrenalglandnotasignificantsourceofandrogens
• Inadultfemales,adrenalandrogenexcesscancausesymptomsofandrogenexcesssuchashirsuiFsm.DeficiencymaycauselossofsomesecondarysexualcharacterisFcs.Inthepostmenopausalstatemaybeanimportantsourceofandrogens.
EffectsofcatecholaminesCardiovascular
Increase in heart rate and force Increased venous return Increased peripheral resistance Visceral Smooth muscle relaxation via β2 actions and contraction via α‐mediated actions Modulation of fluid and electrolyte transport in the gut, kidney, gall bladder via α receptors Metabolic β‐receptor mediated glycogenolysis, lipolysis Increases in diet‐induced and non‐shivering thermogenesis via β receptors Water and electrolyte metabolism Decreased sodium excretion and glomerular filtration due to direct effects on the kidney β‐receptor mediated effects on renin secretion leads to increased aldosterone production with effects on distal sodium handling Serum potassium may be increased as a result of α‐mediated effects on the liver but decreased as a result of β2 receptor‐mediated effects on muscle Hormone secretion The sympatho‐adrenal part of the autonomic nervous system modulates the responses of a number of endocrine systems, including: The renin‐angiotensin‐aldosterone system Increased secretion of glucagon and insulin
ADRENAL STEROID PRODUCTION 1 : 17 ‐hydroxylase (CYP17, P450c17); 17,20: 17,20 lyase (also mediated by CYP17); 3 : 3 ‐hydroxysteroid dehydrogenase; 21: 21‐
hydroxylase (CYP21A2, P450c21); 11 : 11 ‐hydroxylase; (CYP11B1, P450c11); 18 refers to the two‐step process of aldosterone synthase (CYP11B2, P450c11as), resulting in the addition of an hydroxyl group that is then oxidized to an aldehyde group at the 18‐carbon position; 17 R: 17 ‐reductase; 5 R: 5 ‐reductase; DHEA: dehydroepiandrostenedione; DHEAS: DHEA sulfate; A: aromatase (CYP19).
Source: UPTODATE
Case1• A26‐year‐oldwomanwasreferredbecauseofincreasingfacialhair.She
hadhermenarcheat11yearsofagebuthadalwaysnotedirregularperiods.Shewas154cmtallwithaweightof87kg.OnexaminaFon,shewasobesebuthadnoclinicalevidenceofglucocorFcoidormineralocorFcoidexcessandherbloodpressurewasnormal.Shehad,however,excessfacialhair,areolarhairsonthebreasts,malepagernpubichairwithanextensionupthelineaalbainthemidlineofthelowerabdomen.Therewashairontheinnerthighsbutnoneonherback.Therewasnoclitoralhypertrophy,breastatrophyorothersignsofmasculinizaFonsuchasdeepvoiceandmusculardevelopment.
• Herserumtestosteronewasmildlyelevatedaswasher17OHprogesteronelevel.Therewasasignificantincreasein17OHprogestronelevelfollowingACTHsFmulaFon
CongenitalAdrenalHyperplasia(CAH):duetoCYP21A2
• Deficiencyofanyoftheenzymesintheadrenalsteroidsynthesispathwaycancausespecificclinicaldisorders
• ThemostcommonisCYP21A2(21hydroxylase)deficiency.Itisassociatedwith:
• ImpairedsynthesisofcorFsol• impairedsynthesisofaldosterone• IncreasedACTHandincreasedprecursorhormones.Asaconsequence
thereisincreasedandrogenproducFonthatcancausevirilizaFon.• ItmaybeseenininfancywithoutorwithoutsaltwasFng.• MayalsobepickedupfirstinadultswithahistoryofhirsuiFsm,o`en
inferFlity,possiblecliteromegaly• TreatwithglucocorFcoids
ADRENAL STEROID PRODUCTION 1 : 17 ‐hydroxylase (CYP17, P450c17); 17,20: 17,20 lyase (also mediated by CYP17); 3 : 3 ‐hydroxysteroid dehydrogenase; 21: 21‐
hydroxylase (CYP21A2, P450c21); 11 : 11 ‐hydroxylase; (CYP11B1, P450c11); 18 refers to the two‐step process of aldosterone synthase (CYP11B2, P450c11as), resulting in the addition of an hydroxyl group that is then oxidized to an aldehyde group at the 18‐carbon position; 17 R: 17 ‐reductase; 5 R: 5 ‐reductase; DHEA: dehydroepiandrostenedione; DHEAS: DHEA sulfate; A: aromatase (CYP19).
Source: UPTODATE
CAHduetoCYP17deficiency
• MostpaFentspresentatabouttheFmeofexpectedpubertybecauseofhypertension,hypokalemia,andhypogonadism.
• Theremayormaynotbeadrenalinsufficiency,dependinguponthedegreeofthecorFsolsecretorydefect.
• FemalepaFents—Female(46,XX)paFentshaveprimaryamenorrheaandabsentsecondarysexualcharacterisFcs.
• MalepaFents—Male(46,XY)paFentsusuallyhavecompletemalepseudohermaphrodiFsm,withfemaleexternalgenitalia,ablindvagina,nouterusorfallopiantubes,andintraabdominaltestes.
• Source:UPTODATE
CAHfrom3‐BETA‐HYDROXYSTEROIDDEHYDROGENASEdeficiency
• MostpaFentspresentasneonatesorinearlyinfancywithclinicalmanifestaFonsofbothcorFsolandaldosteronedeficiency.
• TheyhavewithfeedingdifficulFes,vomiFng,volumedepleFon,hyponatremia,andhyperkalemia.
• FemalesmayhavemildvirilizaFonoftheirexternalgenitalia,presumablyduetoexcessDHEA,aligleofwhichisconvertedperipherallytotestosterone.
• Maleshavevaryingdegreesoffailureofnormalgenitaldevelopment,rangingfromhypospadiastomalepseudohermaphrodiFsmwithnearlynormalfemaleexternalgenitalia.
Case2
• A33‐year‐oldwomanpresentedwithincreasingskinpigmentaFonandweightloss.Shealsohadnauseaandabdominaldiscomfort.Therewasnoobtainablefamilyhistoryofanyillnessand,apartfromlethargy,shedeniedanyotherproblem.Shehadtwohealthychildren.ShewastakingnomedicaFon.Shehadasupinesystolicbloodpressureof50mmHg(thatbecameunrecordablewhenstanding)
HerbaselinecorFsollevelat8AMwas3mcg/dL.Shewasgiven250mcgofCosyntropin.CorFsolrecheckedat30minwas7mcg/dLandat60minwas9mcg/dL.
ClinicalfeaturesofAdrenalInsufficiency
• Weakness• FaFgue• Anorexia• Weightloss• HyperpigmentaFon• Hypotensionandposturalsymptoms,shockacute.• Nausea/vomiFng• SaltCraving
EFology:PrimaryvsSeondary
• AnACTHsFmulaFontestisusedtodiagnoseadrenalinsufficiency• BaselinecorFsolandACTHchecked.FollowingthisthepaFentreceives
250mcgofcosyntropin.CorFsollevelsarerechecked30minand60minlater.Thetestisadequateifeitherthe30minor60minlevelis18‐20mcg/dLorgreater.
• Iftheresponseisinadequate,theACTHlevelhelpsdetermineifitisprimaryadrenalorsecondarytopituitarydysfuncFon.
• AhighACTHsuggestsprimaryadrenalinsufficiencyandalowACTHlevelsuggestssecondaryadrenalinsufficiency.
CausesofPrimaryAdrenalInsufficiency
• Autoimmune• MetastaFcmalignancy• Adrenalhemorrage• InfecFonssuchasTB• Adrenoleukodystrophy• InfilteraFvedisorderssuchasamyloidosis• CongenFaladrenalhyperplasia• FamilialglucocorFcoiddeficiency(unresponsivetoACTH)• Drugssuchasketoconazole,mitotane,etomadateetc.
CausesofSecondaryAdrenalInsufficiency
• ExogenousSteroids• PituitaryDysfuncFon/HypothalamicdysfuncFon– TumorcompressingcorFcotrophs– Bleed(Sheehans)– Immune(LymphocyFchypophysiFs)– Hemochromatosis– InfiltaraFve(sarcoidosis)
TreatmentofAdrenalInsufiiciency
• InPrimaryAdrenalInsufficiency– ReplaceGlucocorFcoidandPossiblyMineralocorFcoid
• InSecondaryAdrenalInsufficiency– ReplaceGlucocorFcoidInformallpaFentsof‘sickdayrules’–Takex2‐3Fmesmaintenancedoseinacuteillness.
Case3
• A25yearoldfemalepaFentwaspresentedwith50lbweightgainover1year.ShehadfaFgue,hirsuiFsmandincreasingabdominalstriae.ShealsousedtohaveregularperiodsunFlabouttwoyearsagowhenthecyclesbecomeirregular.
• A24hrurinefreecorFsolwasx5theupperlimitofnormalrange
ClinicalFeaturesofcorFsolexcess(Cushing’sSyndromeinthiscase)
• Obesity• Hypertension• HirsuFsm• Striae• Acne• EasyBruising• Osteopenia• MuscleWeakness• Depression(someFmespsychosis)• Menstrualdisorders• Glucoseintolerance• ElevatedLipids• Kidneystones
EFologyofCushing’sSyndrome
• Adrenalhyperplasia.CanbeduetoACTHoversFmulaFon.ACTHcanbefromanectopicsourcesuchassmallcelllungcancer.
• WhentheACTHcomesfromthepituitarythatisCushing’sDisease
• Adrenaladenomas• Adrenalcarcinomas• Iatrogenic
IniFalDiagnosis
• IfCorFsolexcessissuspected,thefollowingtestcanbedone• 24hrurinefreecorFsolvaluesoverx4theupperlimitofnormalare
thoughttobesignificant.• Suppresionwith1mgdexamethasone.At11PM,1mgof
dexamethasoneisgivenandcorFsolischeckedat8AM.InnormalpaFents,thecorFsolsuppressesbelow1.8mcg/dL.FalseposiFvemaybeseeninpaFentsonanFseizuremedicaFonandinrenalfailure.
• MidnightsalivarycorFsol.ThereisdiurnalvariaFonincorFsolrelease.PaFentswithCushingslosethisvariaFon.SalivarycorFsolischeckedonthreeconsecuFvedays.PosiFveifthemajorityareabnormal.ThistestmayalsohelpdisFnguishCushing’sfrompseudocushing’sdisease.
IniFalDiagnosis
• ThenextstepistoassessACTHlevels• WhenthecorFsolexcessisduetoprimaryadrenalover‐producFon(eg.AdrenalAdenoma),ACTHlevelsarelow.
• IfACTHlevelsarehigh,thesourceiseitherthepituitaryorotherFssue(ectopicsource)
Treatment
• SurgeryistheprimarytreatmentforCushing’sSyndrome
• IfthepaFentisnotacandidateforsurgery/hasextensivediseasedrugsthatblockadrenalsteroidsynthesissuchasmetyrapone,ketoconazolecanbetried.
EndocrineReasonsforHypertension
• AdrenalDependent– Pheochromocytoma– Primaryaldosteronism– CushingsSyndrome– HyperdeoxycorFcosteronism
• CongenitalAdrenalHyperplasia11b‐hydroxylasedeficiency17a‐hydroxylasedeficiency• Deoxycortocosterone‐producingtumor• Source:Endocrinehypertension:WilliamYoungfromClevelandClinicEndocrinereview
Pheochromocytomas:• Pheochromocytomasaretumorsofneuroectodermalorigin• TheyresultinincreasedcatecholamineproducFono`enfromtheadrenal
medulla• 2‐8cases/million• Male:FemaleraFois1:1• Usuallypresentsin3‐5thdecadeoflife• CLINICALMANIFESTATIONS
HTNin90‐100%o`enlabileParoxysmalepisodesincludeClassicTriad:Headache,sweaFngand
palpitaFonsChronicvolumedepleFonCardiomyopathy/MISource:WilliamsTextbookofEndocrinology.10thediFonpg555
SynthesisofCatecholamines
MetabolismofCatecholamines
DiagnosisofPheochromocytoma
• 24hrUrineStudies:• Urinemetanephrinesandcatecholaminesaremostreliabletestfor
pheochromocytoma• Ifsuspicionishighurinefreemetanephrinesmaybeuseful• CheckcreaFninewiththeurinestudiestoensureadequacyofthesample• PlasmaStudies:• FracFonatedplasmafreemetanephrinesmaybeused:HighpredicFvevalueofa
negaFvetest
LocalizaFonofthePheochromocytoma
• Sporadicpheochromocytomasarelarge(o`en2‐5cm)ThoseassociatedgeneFcsyndromescanbesmaller.
• 95%areintraabdominal• 90%withintheadrenalgland• CTorMRIcanbeusedforiniFalevaluaFon.MIBGscan(sensiFvity80%,specificity99%)canbeconfirmatory.
• UseMRIinpregnantwomen
ManagementofpaFentswithPheochromocytoma
• PaFentsneedtohaveadrenergicblockade7‐10dayspriortosurgery.SooneriftheyhavehadrecentMIorcardiomyopathy
• Canstartwithalphablocker.Phenoxybenzamineisusedstartat10mgandraiseq2‐3daysFllSBParound100./warnpaFentaboutorthostasisandfaFgue.
• Mayalsousecalciumchannelblocker/nicardipine30mgBID• DONOTuseonlybetablockersmaymakecondiFonsworse
duetounopposedalphaadrenergicsFmulaFon• Onceadequatelyblocked,paFentcanhavePheoresected.
Ruleof10withPheochromocytomas
• 10%areextraadrenal• 10%occurinchildren• 10%aremulFple• 10%recura`ersurgicalremoval.PaFentsshouldhavetesFng
yearlyfollowingsurgery• 10%aremalignant• 10%arefamilial(orpartofsyndromesuchasMEN)Mayneedscreeningforthesesyndromes.• 10%arefoundasadrenalincidentalomas
PrimaryAldosteronism
• DuetooverproducFonofaldosteroneinthezonaglomerulosa
• PaFentspresentwithhypertensionando`enhavehypokalemia.
• MayalsohavenonspecificfindingssuchasfaFgue,headaches,increasedthirst.
• Maybduetoadrenaladenomaorhyperplasia
Diagnosis
• MeasureserumaldosteroneandplasmareninacFvityinAM• SuggesFveifaldosterone/PRAacFvityisgreaterthan30ANDtheabsolute
aldoteroneofgreaterthan15ng/dL.• ConfirmwithSaltloadingtests(canuseeitheroralorIV.UsewithcauFonin
paFentswithseverehypertensionandCHF)– Oralsaltloading,andadequatepotassiumreplacementfor3days.– Thendo24hrurineforaldosterone.Normalvaluesare5‐20mcgin24hours– CanalsodoIVsalineloading(2litersover4hours.CheckcorFsoland
aldosteronebeforeanda`ertheload.PostsalineraFoofaldosteronetocorFsolgreaterthan3seenwithaldosteroneproducingadenoma.
LocalizaFon
• CTorMRIcanbeusedasiniFalstudy• Canconfirmwithadrenalveinsampling.• Rightandle`adrenalveinandvenacavacorFsolandaldosteronemeasured
• CatheterplacementisaccurateiftheadrenalveintovenacavacorFsolraFois5:1.
• Aldosteronelevelsfromle`andrightadrenalveinsarecomparedandgreaterthan4:1raFobetweenthetwosuggestunilateralaldosteoneproducingadenoma.
Treatment
• Dependsondiagnosis• Ifanadenomaisdetected,treatmentissurgery.
ShouldbepreppedpreoperaFvelywithspironolactoneBloodpressureandpotassiumarenormal.
• Ifduetohyperplasia,treatedwithanFhypertensivesspecificallyaldosteroneantogonists(spironolactone,eplerenone)